To Get Help Now
Click Here
 
Today's Date:

Growing Number of Lawsuits Filed Against Plavix Manufacturers

AddThis Social Bookmark Button

Bristol Myers Squibb Co and Sanofi-Aventis filed a request for mass tort designation in New Jersey earlier this month because of  the number of Plavix lawsuits filed by former users.

Plavix, a blood thinner that prevents clots, is a highly popular drug that generated more than $6 billion in U.S. sales alone. The complaints filed against its manufacturers allege that they failed to provide adequate warning about the risk of potentially life threatening side effects, and fraudulently promoted the medication as a safer alternative to the far less expensive aspirin.

The lawsuits claim that both companies were repeatedly cited by the FDA for illegal, off-label promotions,  and unproven claims that said Plavix was safe for the stomach and better than aspirin.

Plaintiffs have suffered serious side effects from Plavix, including gastrointestinal bleeding, severe ulcers, heart attack, stroke and thrombotic thrombocytopenic purpora, or TTP, a rare blood disorder.

A mass tort designation would bring all lawsuits filed in New Jersey where both manufacturers have facilities,  in front of one judge, but unlike a class action lawsuit, each claim would be judged individually, and damages would be decided in each case.

breakinglawsuitnews.com disclaimer: This article: Growing Number of Lawsuits Filed Against Plavix Manufacturers was posted on Thursday, April 28th, 2011 at 8:10 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.